t-PA Prophylaxis to Prevent Catheter-associated Thrombosis and Infection
Status:
Completed
Trial end date:
2019-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to test feasibility of concept, consent and enrollment
rates, and mechanics of study designed to assess if intra-catheter dwells of tissue
plasminogen activator (t-PA) is effective in decreasing the rate of clinically diagnosed
central line associated blood stream infection (CLABSI) or venous thromboembolism (VTE) in
central venous catheters (CVC) compared to standard of care heparin dwell.